New program aims to boost HPV vaccination in HIV-Positive adults
NCT ID NCT05065840
First seen May 19, 2026 · Last updated May 23, 2026 · Updated 3 times
Summary
This study tests a program to help more HIV-positive adults get the HPV vaccine, which can prevent HPV-related cancers. People with HIV are at much higher risk for these cancers. The program gives clinics and doctors tools and training to encourage vaccination. The study will enroll 267 adults aged 18-45 in Georgia who have not completed the HPV vaccine series.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMA VIRUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
AHF Lithonia
Lithonia, Georgia, 30058, United States
-
AID Atlanta
Atlanta, Georgia, 30309, United States
-
Albany Rural Model Clinic
Albany, Georgia, 31705, United States
-
Faebris
Atlanta, Georgia, 30311, United States
Conditions
Explore the condition pages connected to this study.